
Arjo
31,74
SEK
-5,59 %
Mindre end 1K følgere
ARJO B
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Ownership
Investor consensus
-5,59%
-14,49%
-17,26%
-12,47%
-12,99%
-31,68%
-57,57%
-35,54%
+28,87%
Arjo operates in the medical technology industry and focuses on the development, manufacture and distribution of medical equipment for patient management and rehabilitation. The company's products are aimed at healthcare institutions and nursing homes. The business is global with a main presence in Europe, North America and Asia. Arjo was founded in 1957 and is headquartered in Malmö, Sweden.
Læs mereMarkedsværdi
8,65 mia. SEK
Aktieomsætning
16,13 mio. SEK
Omsætning
11,29 mia.
EBIT %
7,91 %
P/E
17,34
Udbytteafkast, %
2,99 %
Finanskalender
29.4
2025
Generalforsamling '25
29.4
2025
Delårsrapport Q1'25
30.4
2025
Årligt udbytte
Alle
Selskabspræsentationer
Selskabsmeddelelser
ViserAlle indholdstyper

Arjo's interim report January-March 2025
Arjo strengthens leading position in patient handling by introducing the new Maxi Move 5 patient floor lift
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Arjo announces date for 2025 Q1 and conference call
Arjo publishes its Annual and Sustainability Report for 2024
Arjo appoints Eva Brike as new Executive Vice President Human Resources & Sustainability and member of the Arjo Management Team
Arjo: NOTICE OF ANNUAL GENERAL MEETING IN ARJO AB (PUBL)

Arjo, Audiocast with teleconference, Q4'24
Arjo's year-end report January-December 2024
Arjo announces date for 2024 year-end report and conference call
Arjo introduces Symbliss - the next-generation integrated bathing system
Christofer Carlsson appointed interim CFO at Arjo
Arjo publishes summary of the result for Q4 2024
Joacim Lindoff leaving position as President & CEO of Arjo
Invitation to Arjo's Capital Markets Update on January 30th, 2025
Arjo announces financial consequences of terminated distribution agreement with Bruin Biometrics
Arjo receives the Allbright Prize 2024
